Concepedia

Author

Nahal Masrour

Imperial College LondonORCID

Also Known As

N. Masrour, Nahal Masrour

69

Publications

408

Citations

10

H-Index

11

Concepts

All Affiliations

Imperial College LondonHammersmith HospitalInstitute of Cancer Research
NM

About

Nahal Masrour is an author at Imperial College London specializing in tumor biology, medicine, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

41

2

Cell Biology

1

1

22

3

Pharmacology

1

1

19

4

Cancer Cell Biology

1

1

22

5

Cancer Genetics

1

1

22

Nahal Masrour

×

10

Publications

401

Citations

10

H-Index

YearCitations

Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer

James M. Flanagan, Angela Wilson, Chail Koo,

Clinical Cancer Research

2016

82

Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis

Edward Curry, Constanze Zeller, Nahal Masrour,

Cancer Research

2018

64

Promoter CpG Island Methylation of Genes in Key Cancer Pathways Associates with Clinical Outcome in High-Grade Serous Ovarian Cancer

Wei Dai, Constanze Zeller, Nahal Masrour,

Clinical Cancer Research

2013

60

Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors

Dionysis Papadatos-Pastos, Wei Yuan, Abhijit Pal,

Journal for ImmunoTherapy of Cancer

2022

47

Clinical translation of [18F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer

Suraiya Dubash, Shairoz Merchant, Kathrin Heinzmann,

European Journal of Nuclear Medicine and Molecular Imaging

2018

42

Loss of O6-methylguanine-DNA methyltransferase confers collateral sensitivity to carmustine in topoisomerase II-mediated doxorubicin resistant triple negative breast cancer cells

Selina Raguz, Caroline Adams, Nahal Masrour,

Biochemical Pharmacology

2012

33

MicroRNA-495/TGF-β/FOXC1 axis regulates multidrug resistance in metaplastic breast cancer cells

Uttom Kumar, Yunhui Hu, Nahal Masrour,

Biochemical Pharmacology

2021

22

Oncogenic EP300 can be targeted with inhibitors of aldo-keto reductases

Zimam Mahmud, Muhammad Asaduzzaman, Uttom Kumar,

Biochemical Pharmacology

2019

19

The DNA Methylomes of Serous Borderline Tumors Reveal Subgroups With Malignant- or Benign-Like Profiles

Constanze Zeller, Wei Dai, Edward Curry,

American Journal Of Pathology

2013

16

Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy

Joanne Evans, Jamie Beaumont, Marta Braga,

European Journal of Cancer

2022

16

Page 1